Category: Asahi Kasei Corp.
Asahi Kasei ends the 2nd phase of its $2.2 billion buyout of Zoll Medical, leaving it with more than 93% of the automated external defibrillator maker.
Asahi Medical completes the first stage of its $2.3 billion acquisition of Zoll Medical, paying $93 apiece for 93.8% of Zoll's outstanding shares and launching a 3-day offering period for the rest.
Chelmsford, Mass.-based resuscitation device maker Zoll Medical (NSDQ:ZOLL) sealed the deal with Japan's Asahi Kasei Corp. (TYO:3407) over the weekend.
Despite tighter rules of proof for inequitable conduct, Becton Dickinson logs a win in a lawsuit filed by Abbott subsidiary Therasense; also, shareholder lawsuits declined last year in the life sciences but nobody told Zoll's investors; Meridian Cos. wins LipoLaser suit; LifeWatch Services settles Medicare fraud case for $19M; smelling a rat: FCPA prosecutions depend on flipping firms; and the Federal Circuit overturns DePuy Spine win in patent spat with USC.
Hill-Rom Holdings says it plans to lay off 200 workers, or 3% of its workforce, in part due to the looming medical device tax; also, AngioDynamics drops $5M on Microsulis; Kips Bay switches NASDAQ markets; Luna Innovations, Intuitive Surgical extend pact; Asahi Kasei begins $2B bid for Zoll; CRO Cetero files for bankruptcy after FDA probe; NASDAQ warns NeuroMetrix; the 6 players that dominate the EMR market; Intuitive Surgical, GE, Hitachi, Philips win federal contracts; plus a Funding Roundup and analysts' ups and downs.
Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.
Zoll soars on news of $2.2B Asahi Kasei acquisition, judge doubles down on $20M jury award to Boston Scientific in Cordis spat, survey shows that jobs and R&D are likely sacrifices in the face of tax burden, White House clears user fee proposal, U.K. docs call for ban on metal-on-metal hips, FDA clears new silicon implant despite consumer protests and senators introduce bi-partisan medical device bill.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.
, News Well
, Capitol Hill
, Plus 7
, Medical Device Tax
, Patent Infringement
, Women's Health
Zoll revels in Wall Street love on news of a $2.2B buyout, VCs press Senate on "IPO On Ramp" bill and the FDA clears a news breast implant maker despite consumer protests.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
ZOLL shares spike 24% on news of a $2.2 billion buyout by Japan's Asahi Kasei Corp., which promises to keep the current management team, business units and operations intact.
Zoll Medical (NSDQ:ZOLL) is winning a lot of Wall Street love this morning on the news of a $2.21 billion cash offer from Asahi Kasei Corp. (TYO:3407).
ZOLL shares jumped 23.5% to $92.74 in morning trading today, after the Chelmsford, Mass.-based resuscitation device maker said it reached an agreement to merge with Asahi.